Beth Sproule

Beth Sproule

University of Toronto

H-index: 38

North America-Canada

About Beth Sproule

Beth Sproule, With an exceptional h-index of 38 and a recent h-index of 25 (since 2020), a distinguished researcher at University of Toronto, specializes in the field of pharmacy, psychopharmacology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Participant Fraud in Virtual Qualitative Substance Use Research: Recommendations and Considerations for Detection and Prevention Based on a Case Study

CJA Reviewers 2023

Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: A population-based cohort study in Ontario, Canada

Opioid Agonist Treatment Retention Among People Initiating Methadone and Buprenorphine Across Diverse Demographic and Geographic Subgroups in Ontario: A Population-based …

Psychosocial and pharmacologic interventions for problematic methamphetamine use: Findings from a scoping review of the literature

Protocol for a qualitative study exploring the pharmacist’s role in supporting postsecondary students with psychotropic medication management

Gender influences on cannabis use among treatment-seeking adults: a qualitative study

Assessing the impact of the slow-release oral morphine drug shortages in Ontario, Canada: A population-based time series analysis

Beth Sproule Information

University

Position

CAMH and

Citations(all)

6433

Citations(since 2020)

2472

Cited By

4921

hIndex(all)

38

hIndex(since 2020)

25

i10Index(all)

69

i10Index(since 2020)

51

Email

University Profile Page

Google Scholar

Beth Sproule Skills & Research Interests

pharmacy

psychopharmacology

Top articles of Beth Sproule

Participant Fraud in Virtual Qualitative Substance Use Research: Recommendations and Considerations for Detection and Prevention Based on a Case Study

Substance Use & Misuse

2024/3/13

Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: A population-based cohort study in Ontario, Canada

Drug and Alcohol Dependence

2024/1/1

Opioid Agonist Treatment Retention Among People Initiating Methadone and Buprenorphine Across Diverse Demographic and Geographic Subgroups in Ontario: A Population-based …

Canadian Journal of Addiction

2023/12/1

Psychosocial and pharmacologic interventions for problematic methamphetamine use: Findings from a scoping review of the literature

2023/10/11

Protocol for a qualitative study exploring the pharmacist’s role in supporting postsecondary students with psychotropic medication management

BMJ open

2023/9/1

Gender influences on cannabis use among treatment-seeking adults: a qualitative study

Drugs: Education, Prevention and Policy

2023/8/22

Assessing the impact of the slow-release oral morphine drug shortages in Ontario, Canada: A population-based time series analysis

International Journal of Drug Policy

2023/8/1

Physician and nurse practitioner perspectives of a modified Routine Opioid Outcome Monitoring (ROOM) Tool

Journal of Primary Health Care

2023/7/13

Experiences of patient-initiated discharge from an inpatient withdrawal management service: a qualitative descriptive study

Journal of Substance Use

2023/4/13

Beth Sproule
Beth Sproule

H-Index: 23

Kristin Cleverley
Kristin Cleverley

H-Index: 11

Separate and combined effects of alcohol and cannabis on mood, subjective experience, cognition and psychomotor performance: A randomized trial

Progress in neuro-psychopharmacology and biological psychiatry

2022/8/30

The Ontario Pharmacy Evidence Network Atlas of Smoking Cessation Services

Canadian Pharmacists Journal/Revue des Pharmaciens du Canada

2022/7

Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population‐based propensity‐score matched cohort study

Addiction

2022/7

The role of pharmacists in opioid stewardship: a scoping review

2022/5/1

Caitlin Carter
Caitlin Carter

H-Index: 0

Beth Sproule
Beth Sproule

H-Index: 23

Impact of changes in opioid funding and clinical policies on rapid tapering of opioids in Ontario, Canada

Pain

2022/1/1

Beth Sproule
Beth Sproule

H-Index: 23

Tara Gomes
Tara Gomes

H-Index: 42

Predictors of and reasons for early discharge from inpatient withdrawal management settings: A scoping review

2022/1

Pharmacists as personalized medicine experts (PRIME): Experiences implementing pharmacist-led pharmacogenomic testing in primary care practices

Pharmacy

2021/12/16

Sex differences in the acute pharmacological and subjective effects of smoked cannabis combined with alcohol in young adults.

Psychology of Addictive Behaviors

2021/8

The role of pharmacists in opioid stewardship: Protocol

Research in Social and Administrative Pharmacy

2021/5/1

Caitlin Carter
Caitlin Carter

H-Index: 0

Beth Sproule
Beth Sproule

H-Index: 23

The role of the pharmacist in the care of patients with chronic pain

2021/4/30

See List of Professors in Beth Sproule University(University of Toronto)